# Tirzepatide, AOD-9604 and BPC-157 Stack: What’s in It

Source: https://pepvault.app/stacks/tirzepatide-aod-9604-bpc-157

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Stacks](https://pepvault.app/stacks) Tirzepatide, AOD-9604 and BPC-157 Stack

Peptide stacks · Weight and metabolism · also called Shred Stack

# Tirzepatide, AOD-9604 and BPC-157 stack: what’s in it and the evidence

Checked November 2026 against our library and study pages [Published by PepVault](https://pepvault.app/guides/how-we-research)

The Shred Stack is a blend of three compounds, tirzepatide, AOD-9604 and BPC-157, that the peptide community runs for fat loss. It isn’t one vial: the amounts the library records per dose are 2.5–10 mg of tirzepatide, 250–300 mcg of AOD-9604 and 250 mcg of BPC-157.

This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.

## What’s in the Shred Stack

The three parts of the Shred Stack

| Part | Amount | What it’s there for | Evidence (library) |
| --- | --- | --- | --- |
| [Tirzepatide](https://pepvault.app/peptides/tirzepatide) | 2.5–10 mg | GIP/GLP-1 dual agonist — appetite suppression & glucose control | Established |
| [AOD-9604](https://pepvault.app/peptides/aod-9604) | 250–300 mcg | Studied for fat breakdown (rodents); no IGF-1 effect | Moderate |
| [BPC-157](https://pepvault.app/peptides/bpc-157) | 250 mcg | Commonly added for GI comfort (gut data from animal studies) | Emerging |

The amount per dose the library records, part by part

- Tirzepatide 2.5–10 mg
- AOD-9604 250–300 mcg
- BPC-157 250 mcg

Each bar runs from the low to the high end of what the library records for each part of the Shred Stack, on one scale.

### [Tirzepatide](https://pepvault.app/peptides/tirzepatide)

In the Shred Stack, tirzepatide is listed for “GIP/GLP-1 dual agonist — appetite suppression & glucose control”. The first dual GIP/GLP-1 receptor agonist: it activates two gut-hormone pathways at once, and in a head-to-head trial it produced more weight loss than semaglutide (20.2% vs 13.7% at 72 weeks).

- [Tirzepatide in the library](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)
- [Tirzepatide: half-life](https://pepvault.app/peptides/tirzepatide/half-life)
- [Tirzepatide: side effects](https://pepvault.app/peptides/tirzepatide/side-effects)
- [Tirzepatide: how long it takes to work](https://pepvault.app/peptides/tirzepatide/how-long-to-work)
- [Tirzepatide: what it’s stacked with](https://pepvault.app/peptides/tirzepatide/stacks)

### [AOD-9604](https://pepvault.app/peptides/aod-9604)

In the Shred Stack, AOD-9604 is listed for “Studied for fat breakdown (rodents); no IGF-1 effect”. A modified fragment of human growth hormone that targets fat metabolism.

- [AOD-9604 in the library](https://pepvault.app/peptides/aod-9604)
- [AOD-9604 dose guide](https://pepvault.app/lab/dosage/aod-9604)
- [AOD-9604: half-life](https://pepvault.app/peptides/aod-9604/half-life)
- [AOD-9604: side effects](https://pepvault.app/peptides/aod-9604/side-effects)
- [AOD-9604: how long it takes to work](https://pepvault.app/peptides/aod-9604/how-long-to-work)

### [BPC-157](https://pepvault.app/peptides/bpc-157)

In the Shred Stack, BPC-157 is listed for “Commonly added for GI comfort (gut data from animal studies)”. A peptide derived from a protective protein in the stomach.

- [BPC-157 in the library](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)
- [BPC-157: half-life](https://pepvault.app/peptides/bpc-157/half-life)
- [BPC-157: side effects](https://pepvault.app/peptides/bpc-157/side-effects)
- [BPC-157: how long it takes to work](https://pepvault.app/peptides/bpc-157/how-long-to-work)
- [BPC-157: what it’s stacked with](https://pepvault.app/peptides/bpc-157/stacks)

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=stacks-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Has the Shred Stack been studied as a combination?

None of our 436 study pages tested the three parts of the Shred Stack together, so the Shred Stack rests on studies of its parts and on community reports.

> What the library says about the evidence for the Shred Stack
>
> Tirz nausea isn't caused by gastric damage, and no trial has tested the combination; the pattern comes from community reports.

The studies of the parts, one by one: 19 study pages on tirzepatide (18 in people), 4 study pages on AOD-9604 (0 in people) and 14 study pages on BPC-157 (2 in people).

Our study pages on each part of the Shred Stack

| Part | Study pages | In people | Strongest study page |
| --- | --- | --- | --- |
| [Tirzepatide](https://pepvault.app/peptides/tirzepatide) | 19 | 18 | [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE (randomized trial, 2026)](https://pepvault.app/research/tirzepatide-embraze-2026) |
| [AOD-9604](https://pepvault.app/peptides/aod-9604) | 4 | 0 | [AOD-9604 knee injections lowered cartilage damage in rabbits (animal study, 2015)](https://pepvault.app/research/aod-9604-kwon-2015) |
| [BPC-157](https://pepvault.app/peptides/bpc-157) | 14 | 2 | [BPC-157: 10 of 12 women reported full interstitial cystitis relief (clinical trial, 2024)](https://pepvault.app/research/bpc-157-lee-2024) |

## What people commonly report on the Shred Stack

**Commonly reported:** easier GI tolerance on the tirzepatide ramp with BPC-157 alongside. BPC-157 alongside makes tirzepatide's nausea and GI upset easier; its gut-protective effects come from animal studies, and it hasn't been tested with GLP-1 drugs. Smoother step-ups, especially the later ones.

These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.

## With the Shred Stack

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### AOD-9604

- [AOD-9604: the full reference](https://pepvault.app/peptides/aod-9604)
- [AOD-9604 dose guide](https://pepvault.app/lab/dosage/aod-9604)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [AOD-9604 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/aod-9604-5mg)
- [BPC-157 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [BPC-157 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)
- [AOD-9604 knee injections lowered cartilage damage in rabbits](https://pepvault.app/research/aod-9604-kwon-2015)
- [AOD-9604 lowered body weight and body fat in obese mice over 14 days](https://pepvault.app/research/aod-9604-heffernan-2001)
- [AOD-9604 cut weight gain by over 50% in obese Zucker rats](https://pepvault.app/research/aod-9604-ng-2000)
- [All 4 studies](https://pepvault.app/research#aod-9604)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Related stacks

- [GLOW Blend](https://pepvault.app/stacks/glow)
- [KLOW Blend](https://pepvault.app/stacks/klow)
- [Wolverine Stack](https://pepvault.app/stacks/wolverine)
- [BPC-157 and GHK-Cu Stack](https://pepvault.app/stacks/bpc-157-ghk-cu)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Vial](https://pepvault.app/glossary/vial)
- [Titration](https://pepvault.app/glossary/titration)
- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)

## Why these are combined

The library gives two reasons for combining the parts of the Shred Stack:

- Tirzepatide cuts appetite via GIP/GLP-1 while AOD-9604 adds fat breakdown (shown in rodents); in people, AOD-9604's larger trial found no weight loss, and the pair has never been tested.
- AOD-9604 is a GH fragment with no IGF-1 or blood-sugar effect in human trials, so it isn't expected to interfere with tirzepatide's metabolic signaling.

> From the library’s notes on the Shred Stack
>
> BPC-157 is commonly added for tirzepatide's GI side effects (nausea, diarrhea), and AOD-9604 for its studied effect on fat breakdown. Two GLP-1 agonists are never combined.

> “Why people add BPC-157 to Tirz”, the Tirzepatide entry’s note (community report)
>
> GI side effects during Tirz titration can be rough, and BPC-157, first studied as a stomach-protecting peptide, is added to ease them. Mechanism fit: BPC-157 is a fragment of a "body protection compound" first isolated from human gastric juice and characterized as gastroprotective in animal studies (gut mucosal integrity, reduced NSAID damage, gut-brain axis modulation).

## How the parts of the Shred Stack are mixed and taken

The Shred Stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.

How each part of the Shred Stack is taken, from its library entry

| Part | Route | How often | Our vial pages |
| --- | --- | --- | --- |
| [Tirzepatide](https://pepvault.app/peptides/tirzepatide) | SubQ injection | Weekly | 5 mg vial, 10 mg vial, 15 mg vial, 30 mg vial, 60 mg vial |
| [AOD-9604](https://pepvault.app/peptides/aod-9604) | SubQ injection | Daily, fasted | 5 mg vial |
| [BPC-157](https://pepvault.app/peptides/bpc-157) | SubQ injection, IM injection, Oral (less studied) | Once or twice daily | 5 mg vial, 10 mg vial |

Our vial pages work out the mix for each part’s own vial, size by size:

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [AOD-9604 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/aod-9604-5mg)
- [BPC-157 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [BPC-157 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [The Reconstitution Lab](https://pepvault.app/lab)

## Compared with running the parts apart

The library’s notes on the Shred Stack don’t compare it with running its parts on their own.

## Safety notes

The library holds no combination safety note on the Shred Stack, so each part’s own notes apply, on its compound page.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

## Questions people ask

### What is in the Shred Stack?

The Shred Stack is a blend of three compounds, tirzepatide, AOD-9604 and BPC-157, that the peptide community runs for fat loss. It isn’t one vial: the amounts the library records per dose are 2.5–10 mg of tirzepatide, 250–300 mcg of AOD-9604 and 250 mcg of BPC-157.

### Has the Shred Stack been studied together?

Not as a combination in any of our study pages: the Shred Stack rests on studies of its parts and on community reports. From the library: Tirz nausea isn't caused by gastric damage, and no trial has tested the combination; the pattern comes from community reports.

### What do people report on the Shred Stack?

Commonly reported: easier GI tolerance on the tirzepatide ramp with BPC-157 alongside. These are reports from people who run it.

### Do the parts of the Shred Stack come in one vial?

No: in the library each part of the Shred Stack is its own compound with its own route and schedule (tirzepatide by SubQ injection, AOD-9604 by SubQ injection and BPC-157 by SubQ injection).

### What does each part of the Shred Stack do?

The library lists tirzepatide for “GIP/GLP-1 dual agonist — appetite suppression & glucose control”, AOD-9604 for “Studied for fat breakdown (rodents); no IGF-1 effect” and BPC-157 for “Commonly added for GI comfort (gut data from animal studies)”.

## Related stacks

- [GLOW Blend BPC-157, TB-500 and GHK-Cu](https://pepvault.app/stacks/glow)
- [KLOW Blend KPV, BPC-157, TB-500 and GHK-Cu](https://pepvault.app/stacks/klow)
- [Wolverine Stack BPC-157 and TB-500](https://pepvault.app/stacks/wolverine)
- [BPC-157 and GHK-Cu Stack BPC-157 and GHK-Cu](https://pepvault.app/stacks/bpc-157-ghk-cu)

## More on these compounds

- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)
- [Peptides for injury recovery and healing](https://pepvault.app/peptides/for/injury-recovery)
- [Every stack and blend](https://pepvault.app/stacks)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=stacks-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=stacks-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=stacks-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With the Shred Stack

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### AOD-9604

- [AOD-9604: the full reference](https://pepvault.app/peptides/aod-9604)
- [AOD-9604 dose guide](https://pepvault.app/lab/dosage/aod-9604)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [AOD-9604 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/aod-9604-5mg)
- [BPC-157 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [BPC-157 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)
- [AOD-9604 knee injections lowered cartilage damage in rabbits](https://pepvault.app/research/aod-9604-kwon-2015)
- [AOD-9604 lowered body weight and body fat in obese mice over 14 days](https://pepvault.app/research/aod-9604-heffernan-2001)
- [AOD-9604 cut weight gain by over 50% in obese Zucker rats](https://pepvault.app/research/aod-9604-ng-2000)
- [All 4 studies](https://pepvault.app/research#aod-9604)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Related stacks

- [GLOW Blend](https://pepvault.app/stacks/glow)
- [KLOW Blend](https://pepvault.app/stacks/klow)
- [Wolverine Stack](https://pepvault.app/stacks/wolverine)
- [BPC-157 and GHK-Cu Stack](https://pepvault.app/stacks/bpc-157-ghk-cu)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Vial](https://pepvault.app/glossary/vial)
- [Titration](https://pepvault.app/glossary/titration)
- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)

<!--promo-->

PepVault for iPhone

## Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=stacks-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Stacks

- [Every stack and blend](https://pepvault.app/stacks)
- [GLOW Blend](https://pepvault.app/stacks/glow)
- [KLOW Blend](https://pepvault.app/stacks/klow)
- [Wolverine Stack](https://pepvault.app/stacks/wolverine)
- [BPC-157 and GHK-Cu Stack](https://pepvault.app/stacks/bpc-157-ghk-cu)

## Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Peptide dosage calculator](https://pepvault.app/tools/peptide-dosage-calculator)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [Studies, in plain English](https://pepvault.app/research)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
